Chi‐Shin Tseng
Papers
2
Total Citations
31
H-Index
2
About
Dr. Chi-Shin Tseng is a pioneering urologic surgeon whose research focuses on advancing robotic-assisted surgery, particularly for prostate cancer. His major contributions lie in the comparative analysis of emerging robotic platforms, notably the Senhance and Da Vinci systems, for radical prostatectomy. Through meticulous studies, Dr. Tseng has evaluated short-term outcomes, learning curves, and cost-effectiveness, providing critical insights that help shape surgical decision-making and healthcare economics. His most cited work, a 2023 study comparing these two robotic systems, has garnered 27 citations, underscoring its influence in the field. By demonstrating that the Senhance system offers comparable outcomes to the established Da Vinci platform while potentially reducing costs, Dr. Tseng’s research empowers hospitals and surgeons to adopt more accessible robotic technologies. His work not only enhances surgical precision and patient recovery but also addresses the pressing need for cost-efficient innovations in urology. Dr. Tseng’s dedication to rigorous comparative effectiveness research makes him a key figure in the evolution of minimally invasive prostate surgery, inspiring both clinical practice and future investigations into robotic surgical systems.
Research Focus
Key Achievements
Top Papers
- 1
- 2